These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 30145829)

  • 1. Higher serum cholesterol and decreased Parkinson's disease risk: A statin-free cohort study.
    Rozani V; Gurevich T; Giladi N; El-Ad B; Tsamir J; Hemo B; Peretz C
    Mov Disord; 2018 Aug; 33(8):1298-1305. PubMed ID: 30145829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term statin use and the risk of Parkinson's disease.
    Friedman B; Lahad A; Dresner Y; Vinker S
    Am J Manag Care; 2013 Aug; 19(8):626-32. PubMed ID: 24304212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statin adherence and the risk of Parkinson's disease: A population-based cohort study.
    Rozani V; Giladi N; El-Ad B; Gurevich T; Tsamir J; Hemo B; Peretz C
    PLoS One; 2017; 12(4):e0175054. PubMed ID: 28388626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of statin use with Parkinson's disease: Dose-response relationship.
    Jeong SM; Jang W; Shin DW
    Mov Disord; 2019 Jul; 34(7):1014-1021. PubMed ID: 30938893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statins, plasma cholesterol, and risk of Parkinson's disease: a prospective study.
    Huang X; Alonso A; Guo X; Umbach DM; Lichtenstein ML; Ballantyne CM; Mailman RB; Mosley TH; Chen H
    Mov Disord; 2015 Apr; 30(4):552-9. PubMed ID: 25639598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anemia in men and increased Parkinson's disease risk: A population-based large scale cohort study.
    Rozani V; Giladi N; Gurevich T; El-Ad B; Tsamir J; Hemo B; Peretz C
    Parkinsonism Relat Disord; 2019 Jul; 64():90-96. PubMed ID: 30922776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Total cholesterol and the risk of Parkinson disease.
    Hu G; Antikainen R; Jousilahti P; Kivipelto M; Tuomilehto J
    Neurology; 2008 May; 70(21):1972-9. PubMed ID: 18401018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic syndrome and risk of Parkinson disease: A nationwide cohort study.
    Nam GE; Kim SM; Han K; Kim NH; Chung HS; Kim JW; Han B; Cho SJ; Yu JH; Park YG; Choi KM
    PLoS Med; 2018 Aug; 15(8):e1002640. PubMed ID: 30130376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parkinson disease male-to-female ratios increase with age: French nationwide study and meta-analysis.
    Moisan F; Kab S; Mohamed F; Canonico M; Le Guern M; Quintin C; Carcaillon L; Nicolau J; Duport N; Singh-Manoux A; Boussac-Zarebska M; Elbaz A
    J Neurol Neurosurg Psychiatry; 2016 Sep; 87(9):952-7. PubMed ID: 26701996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urate and the risk of Parkinson's disease in men and women.
    Cortese M; Riise T; Engeland A; Ascherio A; Bjørnevik K
    Parkinsonism Relat Disord; 2018 Jul; 52():76-82. PubMed ID: 29615298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of serum lipid levels over time with survival in incident peritoneal dialysis patients.
    Park CH; Kang EW; Park JT; Han SH; Yoo TH; Kang SW; Chang TI
    J Clin Lipidol; 2017; 11(4):945-954.e3. PubMed ID: 28669685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low LDL cholesterol and increased risk of Parkinson's disease: prospective results from Honolulu-Asia Aging Study.
    Huang X; Abbott RD; Petrovitch H; Mailman RB; Ross GW
    Mov Disord; 2008 May; 23(7):1013-1018. PubMed ID: 18381649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of High-Density Lipoprotein Cholesterol Variability and the Risk of Developing Parkinson Disease.
    Park JH; Lee CW; Nam MJ; Kim H; Kwon DY; Yoo JW; Lee KN; Han K; Jung JH; Park YG; Kim DH
    Neurology; 2021 Mar; 96(10):e1391-e1401. PubMed ID: 33536275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statin Use and Incidence of Parkinson's Disease in Women from the French E3N Cohort Study.
    Nguyen TTH; Fournier A; Courtois É; Artaud F; Escolano S; Tubert-Bitter P; Boutron-Ruault MC; Degaey I; Roze E; Canonico M; Ahmed I; Thiébaut ACM; Elbaz A
    Mov Disord; 2023 May; 38(5):854-865. PubMed ID: 36788159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A systematic review and meta-analysis of serum cholesterol and triglyceride levels in patients with Parkinson's disease.
    Fu X; Wang Y; He X; Li H; Liu H; Zhang X
    Lipids Health Dis; 2020 May; 19(1):97. PubMed ID: 32430016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of a refined drug tracer algorithm to estimate prevalence and incidence of Parkinson's disease in a large israeli population.
    Chillag-Talmor O; Giladi N; Linn S; Gurevich T; El-Ad B; Silverman B; Friedman N; Peretz C
    J Parkinsons Dis; 2011; 1(1):35-47. PubMed ID: 23939255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of serum cholesterol with Parkinson's disease in a cohort of statin-free individuals.
    Lv Y; Xu B; Zhang X; Chen C; Gao Y; Li N
    Brain Behav; 2022 Jan; 12(1):e2454. PubMed ID: 34894416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum non-high-density lipoprotein cholesterol levels and the incidence of ischemic stroke in a Japanese population: the Jichi Medical School cohort study.
    Kakehi E; Kotani K; Ishikawa S; Gotoh T; Kayaba K; Nakamura Y; Kajii E
    Asia Pac J Public Health; 2015 Mar; 27(2):NP535-43. PubMed ID: 23430886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A 12-year population-based study of freezing of gait in Parkinson's disease.
    Forsaa EB; Larsen JP; Wentzel-Larsen T; Alves G
    Parkinsonism Relat Disord; 2015 Mar; 21(3):254-8. PubMed ID: 25603767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of Parkinson's disease following severe constipation: a nationwide population-based cohort study.
    Lin CH; Lin JW; Liu YC; Chang CH; Wu RM
    Parkinsonism Relat Disord; 2014 Dec; 20(12):1371-5. PubMed ID: 25293395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.